Table 1.
Baseline Characteristics of Patients Enrolled in Vitamin D and Omega‐3 Trial‐Cardiac Structure and Function at the Time of Randomization, Stratified by Treatment Groups
| Baseline characteristics | Combined, N=1025 | Vitamin D, N=509 | Placebo, N=516 |
|---|---|---|---|
| Age, y | 64.4 [60.3, 68.7] | 64.3 [60.3, 68.4] | 64.5 [60.3, 69.1] |
| Men | 522 (51%) | 258 (51%) | 264 (51%) |
| Race | |||
| Non‐Hispanic White | 849 (85%) | 420 (84%) | 429 (85%) |
| Black | 86 (9%) | 41 (8%) | 45 (9%) |
| Hispanic | 29 (3%) | 12 (2%) | 17 (3%) |
| Asian/Pacific | 16 (2%) | 11 (2%) | 5 (1%) |
| American Indian/Alaska Native | 5 (1%) | 2 (0%) | 3 (1%) |
| Other or unknown | 19 (2%) | 14 (3%) | 5 (1%) |
| BMI, kg/m2 | 26.3 [23.9, 29.6] | 26.3 [23.9, 29.2] | 26.3 [23.8, 30.0] |
| Systolic BP, mm Hg | |||
| <110 | 73 (9%) | 34 (9%) | 39 (10%) |
| 110–119 | 222 (28%) | 117 (30%) | 105 (26%) |
| 120–129 | 293 (37%) | 136 (35%) | 157 (39%) |
| 130–139 | 166 (21%) | 83 (21%) | 83 (20%) |
| 140–149 | 40 (5%) | 20 (5%) | 20 (5%) |
| 150–159 | 5 (1%) | 4 (1%) | 1 (0%) |
| 160–169 | 1 (0%) | 0 (0%) | 1 (0%) |
| 170–179 | 1 (0%) | 0 (0%) | 1 (0%) |
| Hypertension | 449 (44%) | 215 (42%) | 234 (46%) |
| n−3 fatty acids | 510 (50%) | 254 (50%) | 256 (50%) |
| 25(OH) D level, ng/mL | 28.0 [22.0, 34.0] | 27.0 [22.0, 34.0] | 29.0 [22.0, 34.0] |
Values represent median [25th, 75th percentiles] or n (%). BMI indicates body mass index; and BP, blood pressure.